Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.

Autor: Zeyen, Thomas, Paech, Daniel, Weller, Johannes, Schäfer, Niklas, Tzaridis, Theophilos, Duffy, Cathrina, Nitsch, Louisa, Schneider, Matthias, Potthoff, Anna-Laura, Steinbach, Joachim Peter, Hau, Peter, Schlegel, Uwe, Seidel, Clemens, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Zeiner, Pia Susan, Tabatabai, Ghazaleh, Galldiks, Norbert, Stummer, Walter

Publikováno v: Journal of Neuro-Oncology; Nov2023, Vol. 165 Issue 2, p387-387, 1p

Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ.

Autor: Zeyen T; Department of Neurooncology, Center for Neurology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Böhm L; Department of Neurooncology, Center for Neurology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Paech D; Department of Neuroradiology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Schäfer N; Department of Neurooncology, Center for Neurology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Tzaridis T; Department of Neurooncology, Center for Neurology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Duffy C; Department of Neurooncology, Center for Neurology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Nitsch L; Department of Vascular Neurology, Center for Neurology, University Hospital Bonn, Bonn, Germany., Schneider M; Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Potthoff AL; Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Schneider-Rothhaar JL; Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Steinbach JP; Dr. Senckenberg Institute of Neurooncology, University of Frankfurt, Frankfurt,Germany., Hau P; Department of Neurology and Wilhelm Sander NeuroOncology Unit, University Hospital Regensburg, Regensburg, Germany., Kowalski T; Department of Neurology, University Hospital Knappschaftskrankenhaus, Ruhr University Bochum., Seidel C; Department of Radiation Oncology University of Leipzig, Leipzig, Germany., Krex D; Technische Universität Dresden, Faculty of Medicine and University Hospital Carl Gustav Carus, Department of Neurosurgery, Fetscherstrasse 74, 01307 Dresden, Germany., Grauer O; Department of Neurology University of Münster, Münster, Germany., Goldbrunner R; Center of Neurosurgery Department of General Neurosurgery University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO ABCD)., Zeiner PS; Dr. Senckenberg Institute of Neurooncology, University of Frankfurt, Frankfurt,Germany., Tabatabai G; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie, Institute for Clinical Brain Research, Eberhard Karls University Tübingen.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard Karls University Tübingen., Galldiks N; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany and Research Center Juelich, Inst. of Neuroscience and Medicine (INM-3), Juelich, Germany.; Center for Integrated Oncology (CIO ABCD)., Stummer W; Department of Neurosurgery, University of Münster, Münster, Germany., Hattingen E; Department of Neuroradiology, University Hospital Frankfurt, 60590 Frankfurt am Main, Germany., Glas M; Division of Clinical Neurooncology, Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site University Medicine Essen, Hufelandstr. 55, 45147 Essen, Germany., Gkika E; Department of Radiation Oncology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Vatter H; Department of Neurosurgery, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Radbruch A; Department of Neuroradiology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Herrlinger U; Department of Neurooncology, Center for Neurology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Weller J; Department of Neurooncology, Center for Neurology, University Hospital Bonn, Bonn, Germany.; Department of Vascular Neurology, Center for Neurology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD)., Schaub C; Department of Neurooncology, Center for Neurology, University Hospital Bonn, Bonn, Germany.; Center for Integrated Oncology (CIO ABCD).

Publikováno v: Neuro-oncology [Neuro Oncol] 2024 Oct 01. Date of Electronic Publication: 2024 Oct 01.